Mark Samaan

5.1k total citations · 1 hit paper
74 papers, 1.2k citations indexed

About

Mark Samaan is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Mark Samaan has authored 74 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Genetics, 37 papers in Epidemiology and 28 papers in Surgery. Recurrent topics in Mark Samaan's work include Inflammatory Bowel Disease (50 papers), Microscopic Colitis (31 papers) and Biosimilars and Bioanalytical Methods (10 papers). Mark Samaan is often cited by papers focused on Inflammatory Bowel Disease (50 papers), Microscopic Colitis (31 papers) and Biosimilars and Bioanalytical Methods (10 papers). Mark Samaan collaborates with scholars based in United Kingdom, Netherlands and Canada. Mark Samaan's co-authors include Peter M. Irving, Brian G. Feagan, Mahmoud Mosli, Geert D’Haens, Esha Sharma, Reena Khanna, Guangyong Zou, Nick Powell, Aditi Kumar and Vipul Jairath and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Gut.

In The Last Decade

Mark Samaan

68 papers receiving 1.2k citations

Hit Papers

Iron deficiency anaemia: pathophysiology, assessment, pra... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Samaan United Kingdom 19 658 483 402 266 170 74 1.2k
Alessandra Zilli Italy 21 521 0.8× 638 1.3× 568 1.4× 274 1.0× 142 0.8× 96 1.4k
Irene Modesto United States 20 834 1.3× 584 1.2× 313 0.8× 156 0.6× 135 0.8× 66 1.2k
Iván Guerra Spain 20 470 0.7× 281 0.6× 364 0.9× 144 0.5× 192 1.1× 73 1.0k
Yago González‐Lama Spain 19 989 1.5× 798 1.7× 402 1.0× 66 0.2× 192 1.1× 51 1.4k
Ayanna Lewis United States 4 1.3k 2.1× 998 2.1× 552 1.4× 173 0.7× 179 1.1× 10 1.5k
Helena Tavares de Sousa Portugal 13 904 1.4× 658 1.4× 320 0.8× 106 0.4× 232 1.4× 39 1.2k
Robert Bagin United States 17 284 0.4× 298 0.6× 244 0.6× 188 0.7× 149 0.9× 25 1.1k
Benjamin Pariente France 23 1.4k 2.2× 1.1k 2.2× 665 1.7× 155 0.6× 420 2.5× 88 1.8k
Sophie Restellini Switzerland 17 336 0.5× 381 0.8× 291 0.7× 259 1.0× 77 0.5× 53 893
Neena Sood India 18 409 0.6× 606 1.3× 405 1.0× 180 0.7× 70 0.4× 112 1.4k

Countries citing papers authored by Mark Samaan

Since Specialization
Citations

This map shows the geographic impact of Mark Samaan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Samaan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Samaan more than expected).

Fields of papers citing papers by Mark Samaan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Samaan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Samaan. The network helps show where Mark Samaan may publish in the future.

Co-authorship network of co-authors of Mark Samaan

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Samaan. A scholar is included among the top collaborators of Mark Samaan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Samaan. Mark Samaan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Honap, Sailish, Bénédicte Caron, Jacob E. Ollech, et al.. (2025). Anti-tumor Necrosis Factor Drug Concentration Is Not Associated with Disease Outcomes in Pouchitis: A Retrospective, International Study. Digestive Diseases and Sciences. 70(4). 1320–1327. 1 indexed citations
2.
3.
Pittet, Valérie, Peter Bossuyt, Jurij Hanžel, et al.. (2024). Baseline Data and Measurement Instruments Reported in Observational Studies in Inflammatory Bowel Disease: Results from a Systematic Review. Journal of Crohn s and Colitis. 18(6). 875–884. 1 indexed citations
4.
Kemp, Karen, Mark Samaan, Ajay Verma, & Alan Lobo. (2024). Crohn’s disease management: translating STRIDE-II for UK clinical practice. Therapeutic Advances in Gastroenterology. 17. 1118463861–1118463861.
5.
Dawson, Patrick, Esha Sharma, Robin Dart, et al.. (2022). P19 Risankizumab in crohn’s disease: real world experience from a pre-approval access program. Poster presentations. A45.2–A46. 2 indexed citations
6.
Honap, Sailish, Esha Sharma, Joel Mawdsley, et al.. (2022). P430 Longer-term tofacitinib effectiveness for the treatment of ulcerative colitis: Two-year outcomes from a UK observational cohort study. Journal of Crohn s and Colitis. 16(Supplement_1). i414–i415. 2 indexed citations
7.
Torrente, Franco, Susanna Meade, Eric I. Benchimol, et al.. (2022). Thromboprophylaxis Use in Paediatric Inflammatory Bowel Disease: An International RAND Appropriateness Panel. Journal of Crohn s and Colitis. 16(10). 1609–1616. 7 indexed citations
8.
Hanžel, Jurij, Peter Bossuyt, Valérie Pittet, et al.. (2022). Development of a Core Outcome Set for Real-world Data in Inflammatory Bowel Disease: A European Crohn’s and Colitis Organisation [ECCO] Position Paper. Journal of Crohn s and Colitis. 17(3). 311–317. 9 indexed citations
9.
Bossuyt, Peter, Valérie Pittet, Jurij Hanžel, et al.. (2022). A Narrative Systematic Review and Categorisation of Outcomes in Inflammatory Bowel Disease to Inform a Core Outcome Set for Real-world Evidence. Journal of Crohn s and Colitis. 16(10). 1511–1522. 7 indexed citations
10.
Meade, Susanna, et al.. (2021). Emerging Treatments for Crohn's Disease: Cells, Surgery, and Novel Therapeutics. SHILAP Revista de lepidopterología. 2 indexed citations
11.
Honap, Sailish, Gareth Parkes, Mark Samaan, et al.. (2021). P103 Ustekinumab: medium-term outcomes from a uk multi-centre real-world cohort. A94.2–A95. 1 indexed citations
12.
Samaan, Mark, Shuvra Ray, Joel Mawdsley, et al.. (2021). P143 Validation of the two-item UC PRO2 against SCCAI, biochemical disease activity and quality of life. A116.2–A117. 1 indexed citations
13.
Honap, Sailish, Susanna Meade, Hajir Ibraheim, et al.. (2021). Effectiveness and Safety of Ustekinumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Digestive Diseases and Sciences. 67(3). 1018–1035. 55 indexed citations
14.
15.
Samaan, Mark, Bo Shen, Mahmoud Mosli, et al.. (2018). Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis. Gastrointestinal Endoscopy. 88(2). 360–369.e2. 26 indexed citations
16.
Samaan, Mark, Carl A. J. Puylaert, Barrett G. Levesque, et al.. (2017). The development of a magnetic resonance imaging index for fistulising Crohn's disease. Alimentary Pharmacology & Therapeutics. 46(5). 516–528. 54 indexed citations
17.
Samaan, Mark, Mahmoud Mosli, William J. Sandborn, et al.. (2014). A Systematic Review of the Measurement of Endoscopic Healing in Ulcerative Colitis Clinical Trials. Inflammatory Bowel Diseases. 20(8). 1465–1471. 63 indexed citations
18.
Langmead, Louise, et al.. (2013). PTH-072 A Retrospective Review of Video Capsule Endoscopy (VCE). Gut. 62(Suppl 1). A240.2–A240. 1 indexed citations
19.
Samaan, Mark, et al.. (2013). Small bowel video capsule endoscopy: an overview. Expert Review of Gastroenterology & Hepatology. 7(4). 323–329. 32 indexed citations
20.
Samaan, Mark, et al.. (2008). Laparoscopic Adjustable Gastric Banding for Morbid Obesity in a Patient with Situs Inversus Totalis. Obesity Surgery. 18(7). 898–901. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026